Contract W81XWH20P0093
Repligen Corporation · Department Of Defense · May 20, 2020
Repligen Corporation was awarded a federal contract by Department Of Defense (Department Of The Army) on May 20, 2020 for $43,000 of work in biological product (except diagnostic) manufacturing. Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 12, 2021.
Contract details
- PIID
- W81XWH20P0093
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Silver Spring, MD
- First action
- May 20, 2020
- Latest action
- January 12, 2021
Description
KMPI SYSTEM
Modification timeline
-
January 12, 2021Mod P00001$0
-
May 20, 2020Base award$42.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Greer Laboratories, Inc. | Department Of Defense | December 19, 2025 | $470.4K |
| Greer Laboratories, Inc. | Department Of Defense | December 18, 2025 | $0 |
| Lifestream Blood Bank | Department Of Defense | December 18, 2025 | $29.7K |
| Kemp Proteins, Llc | Department Of Defense | December 18, 2025 | $40.0K |
| Applied Dna Sciences, Inc. | Department Of Defense | December 15, 2025 | $1 |
| Sanofi Vaccines Us Inc. | Department Of Defense | December 12, 2025 | $486.7K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81XWH20P0093?
Contract W81XWH20P0093 is a federal contract awarded to Repligen Corporation by Department Of Defense on May 20, 2020 for $43,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract W81XWH20P0093?
Repligen Corporation won contract W81XWH20P0093 from Department Of Defense.
How much is contract W81XWH20P0093 worth?
Contract W81XWH20P0093 has obligated $43,000 to date.